A
24.11
-0.69 (-2.78%)
| 前收盘价格 | 24.80 |
| 收盘价格 | 23.89 |
| 成交量 | 1,741,918 |
| 平均成交量 (3个月) | 1,508,354 |
| 市值 | 2,898,311,424 |
| 价格/销量 (P/S) | 253.94 |
| 股市价格/股市净资产 (P/B) | 2.09 |
| 52周波幅 | |
| 利润日期 | 7 May 2025 - 12 May 2025 |
| 营业利益率 (TTM) | -4,069.63% |
| 稀释每股收益 (EPS TTM) | -2.89 |
| 季度收入增长率 (YOY) | 35.60% |
| 总债务/股东权益 (D/E MRQ) | 0.48% |
| 流动比率 (MRQ) | 15.73 |
| 营业现金流 (OCF TTM) | -300.87 M |
| 杠杆自由现金流 (LFCF TTM) | -197.47 M |
| 资产报酬率 (ROA TTM) | -21.60% |
| 股东权益报酬率 (ROE TTM) | -33.47% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Avidity Biosciences, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
0.1
| 分析师共识 | 3.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 1.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.10 |
|
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 5.03% |
| 机构持股比例 | 107.34% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 72.00 (BMO Capital, 198.63%) | 购买 |
| 72.00 (HC Wainwright & Co., 198.63%) | 购买 | |
| 中 | 67.00 (177.89%) | |
| 低 | 48.00 (B of A Securities, 99.09%) | 购买 |
| 平均值 | 64.56 (167.77%) | |
| 总计 | 9 购买 | |
| 平均价格@调整类型 | 30.63 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Needham | 09 Apr 2025 | 60.00 (148.86%) | 购买 | 24.80 |
| 17 Mar 2025 | 60.00 (148.86%) | 购买 | 33.83 | |
| HC Wainwright & Co. | 18 Mar 2025 | 72.00 (198.63%) | 购买 | 30.48 |
| 17 Mar 2025 | 72.00 (198.63%) | 购买 | 33.83 | |
| Chardan Capital | 17 Mar 2025 | 65.00 (169.60%) | 购买 | 33.83 |
| 28 Feb 2025 | 65.00 (169.60%) | 购买 | 30.64 | |
| Citigroup | 13 Mar 2025 | 70.00 (190.34%) | 购买 | 32.13 |
| BMO Capital | 12 Mar 2025 | 72.00 (198.63%) | 购买 | 32.61 |
| B of A Securities | 10 Mar 2025 | 48.00 (99.09%) | 购买 | 30.04 |
| Scotiabank | 07 Mar 2025 | 70.00 (190.34%) | 购买 | 30.29 |
| Barclays | 28 Feb 2025 | 57.00 (136.42%) | 购买 | 30.64 |
| RBC Capital | 21 Jan 2025 | 67.00 (177.89%) | 购买 | 30.84 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合